Sutro Biopharma

Sutro Biopharma: Focused on developing next generation antibody drug conjugates (ADCs) and other complex biologics for cancer through its proprietary cell-free platform, a scalable biochemical cell-free protein synthesis platforms that enable rapid and systematic evaluation of protein structure-activity relationships. The company’s FolRα-targeting ADC (STRO-002) in ovarian cancer is currently in Ph 1 with dose-expansion data expected in 2H 2021. Enrollment is ongoing for CD74-targeting ADC (STRO-001) in the Ph 1 dose-escalation in B-cell malignancies. Additional programs in preclinical/discovery are Tissue Factor ADC, ROR1 ADC, IL-12, IFNα, 5T4-TCE bispecific. Sutro has three high value collaborations with BMS (BCMA ADC), Merck (cytokines), and EMD Serono (MUC1-EGFR bispecific ADC).
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Autoimmune, Infectious Disease, Oncology
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
Website:
Address:
310 Utah Ave
Suite 150
South San Francisco, CA 94080
United States

Company Participants at Sutro Biopharma STRO-002 Data Virtual KOL Event 2020

  • Annie Chang, VP Investor Relations
  • Arturo Molina, MD, MS, FACP, Chief Medical Officer
  • Bill Newell, Chief Executive Officer
  • Edward Albini, Chief Financial Officer
  • Trevor Hallam, Ph.D., Chief Scientific Officer

Top 10 Holders of Sutro Biopharma, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Suvretta Capital Management LLC 8.05 3,732,400 21.50 13F 3/31/22
Franklin Advisers, Inc. 8.04 3,728,596 21.48 13F 3/31/22
BVF, Inc. 7.43 3,447,946 19.86 13F 3/31/22
BVF Partners LP 6.83 3,160,416 18.20 Stakes 1/7/22
Eventide Asset Management LLC 5.84 2,708,975 15.60 13F 3/31/22
State Street Corp. 5.70 2,642,486 15.22 13F 3/31/22
Millennium Management LLC 5.16 2,422,673 13.95 Stakes 7/1/22
Vanguard Group, Inc. (Subfiler) 4.69 2,173,284 12.52 13F 3/31/22
The Vanguard Group, Inc. 4.38 2,052,384 11.82 Funds 6/30/22
BlackRock Fund Advisors 4.31 1,998,479 11.51 13F 3/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.